173 related articles for article (PubMed ID: 21349669)
21. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of bone microvascularization after osteocutaneous flap transplantation using contrast-enhanced ultrasound (CEUS).
Geis S; Prantl L; Mueller S; Gosau M; Lamby P; Jung EM
Ultraschall Med; 2013 Jun; 34(3):272-9. PubMed ID: 23709242
[TBL] [Abstract][Full Text] [Related]
23. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
[TBL] [Abstract][Full Text] [Related]
24. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.
Kuorda H; Abe T; Fujiwara Y; Okamoto T; Yonezawa M; Sato H; Endo K; Oikawa T; Sawara K; Takikawa Y
World J Gastroenterol; 2019 May; 25(19):2365-2372. PubMed ID: 31148907
[TBL] [Abstract][Full Text] [Related]
25. Correlations between the time-intensity parameters of contrast-enhanced ultrasound and clinical prognosis of hepatocellular carcinoma.
Yang YL; Yang RJ; Liu X; Liu J; Chao LJ; Duan YY
Clin Imaging; 2013; 37(2):308-12. PubMed ID: 23465984
[TBL] [Abstract][Full Text] [Related]
26. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
28. Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after Resection.
Zou RH; Lin QG; Huang W; Li XL; Cao Y; Zhang J; Zhou JH; Li AH; Beretta L; Qian CN
Ultrasound Med Biol; 2015 Oct; 41(10):2621-30. PubMed ID: 26210785
[TBL] [Abstract][Full Text] [Related]
29. Correlation of contrast-enhanced ultrasound with two distinct types of blood vessels for the assessment of angiogenesis in lewis lung carcinoma.
Zhuo J; Fu W; Liu S
Ultraschall Med; 2014 Oct; 35(5):468-72. PubMed ID: 24327471
[TBL] [Abstract][Full Text] [Related]
30. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver.
Park YN; Yang CP; Fernandez GJ; Cubukcu O; Thung SN; Theise ND
Am J Surg Pathol; 1998 Jun; 22(6):656-62. PubMed ID: 9630172
[TBL] [Abstract][Full Text] [Related]
31. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
[TBL] [Abstract][Full Text] [Related]
32. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
[TBL] [Abstract][Full Text] [Related]
33. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
Schaible J; Stroszczynski C; Beyer LP; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
[TBL] [Abstract][Full Text] [Related]
34. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
35. Semiquantitative characterization of hepatocellular carcinoma (HCC)--perfusion with contrast-enhanced ultrasound and perfusion analysis.
Schacherer D; Girlich C; Wiest R; Büttner R; Schölmerich J; Feuerbach S; Zorger N; Hamer OW; Jung EM
Clin Hemorheol Microcirc; 2010; 44(2):97-105. PubMed ID: 20203364
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
37. Quantitative dynamic contrast-enhanced ultrasound may help predict the outcome of hepatocellular carcinoma after microwave ablation.
Zhan Y; Zhou F; Yu X; Luo F; Liu F; Liang P; Cheng Z; Han Z; Yu J
Int J Hyperthermia; 2019 Jan; 35(1):105-111. PubMed ID: 30300039
[TBL] [Abstract][Full Text] [Related]
38. Single-level dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels.
Chen WX; Min PQ; Song B; Xiao BL; Liu Y; Ge YH
World J Gastroenterol; 2004 Jan; 10(1):67-72. PubMed ID: 14695771
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
40. Quantification of carotid plaque neovascularization using contrast-enhanced ultrasound with histopathologic validation.
Li C; He W; Guo D; Chen L; Jin X; Wang W; Huang B; Wang W
Ultrasound Med Biol; 2014 Aug; 40(8):1827-33. PubMed ID: 24798387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
